Latest AI and machine learning research in oncology/hematology for healthcare professionals.
BACKGROUND: Bladder cancer is the 11th most common cancer in the United Kingdom, with approximately ...
Oncology clinical trials are often characterized by slow accrual, high failure rates and limited gen...
BACKGROUND: Interval cancer, breast cancer detected after a negative screening examination but befor...
BACKGROUND: The transformation from benign to malignant breast tissue represents a complex biologica...
BACKGROUND: Human visual performance in diagnosing and detecting peritoneal metastases (PM) during l...
AIM: Coronary artery disease (CAD) remains a leading cause of morbidity and mortality worldwide. Com...
The discovery of CAP-Gly domain-containing linker protein 1(CLIP1)-Leukocyte tyrosine kinase (LTK) a...
BACKGROUND: Current endoscopic retrograde cholangiopancreatography (ERCP) and cholangioscopic-based ...
Interpatient variability in chemotherapy response and toxicity remains a major challenge in oncology...
The discussion on precision oncology integrates multiomics technologies and artificial intelligence,...
INTRODUCTION: Infection is a common and potentially fatal complication during the treatment of hemat...
Metastatic prostate cancer is a clinically and molecularly heterogeneous disease. Under the selectiv...
BACKGROUND: Vacuum-assisted breast biopsy (VABB) enables minimally invasive sampling of breast lesio...
BACKGROUND: Clinical course information, including disease onset, episode recurrence, and hospitaliz...
BACKGROUND: Real-time breath metabolomic profiling may detect lung cancer-associated breath features...
BACKGROUND: Hepatocellular carcinoma (HCC) frequently develops in the setting of chronic hepatitis B...
Tertiary lymphoid structures (TLS) are organized ectopic immune aggregates within the tumor microenv...
Inflammatory breast cancer (IBC) is a rare and highly aggressive subtype of breast cancer, associate...
A modified Spider Shaped Four Element Multi Input Multi Output Antenna (SSFEMIMOA) is suggested for ...
BACKGROUND: Diffuse Gastric Cancer (DGC) is an aggressive subtype with a poor prognosis and a lack o...
Fibroblast growth factor receptor (FGFR) alterations have emerged as clinically actionable biomarker...